Nuwellis Inc NUWE
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
Nuwellis Submits FDA 510(k) to Expand Aquadex SmartFlow® Indication to Include Pediatric Patients Weighing 5 kg and Above
Nuwellis to Report Third Quarter 2026 Financial Results on November 12
Nuwellis Announces Acceptance of Multicenter Pediatric Aquadex Study in Pediatric Nephrology
Nuwellis to Convene Pediatric Medical & Nursing Advisory Board to Advance Development of Vivian™ Pediatric CRRT System
Nuwellis to Highlight Advancements in Fluid Management Across Pediatric Care, Critical Care, and Heart Failure at Leading October Medical Conferences
Nuwellis Reports Strong Aquadex Console Adoption, with 31 Aquadex SmartFlow Consoles Sold Year-to-Date, Meaningfully Expanding Recurring Revenue Opportunity
Nuwellis Strengthens Organization with Appointment of Brian Johnson as Director of Quality and Regulatory Affairs
Nuwellis Advances Financial Efficiency Strategy with Improved Gross Margins
Trading Information
- Previous Close Price
- $4.66
- Day Range
- $4.43–4.62
- 52-Week Range
- $2.52–1,556.07
- Bid/Ask
- $4.45 / $4.59
- Shares Outstanding
- 405,252.00
- Market Cap
- $1.85M
- Volume/Avg
- 2,723 / 822,376
Key Statistics
- Price/Earnings (Normalized)
- 0.00
- Price/Sales
- 0.00
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Nuwellis Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Nuwellis has one reportable segment: fluid overload.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 38
- Website
- https://www.nuwellis.com
Valuation
Metric | NUWE |
|---|---|
Price/Earnings (Normalized) | 0.00 |
Price/Book Value | — |
Price/Sales | 0.00 |
Price/Cash Flow | — |
Price/Earnings
NUWE
Financial Strength
Metric | NUWE |
|---|---|
Quick Ratio | 1.36 |
Current Ratio | 1.97 |
Interest Coverage | −0.86 |
Quick Ratio
NUWE
Profitability
Metric | NUWE |
|---|---|
Return on Assets (Normalized) | −239.45% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
NUWE
Medical Devices Industry Comparables
1-Day Chart | Name | Price | Morningstar Rating for Stocks | Capital Allocation | Economic Moat | Market Cap |
|---|---|---|---|---|---|---|
| Abbott Laboratories ABT | LOCK|lH>$@K | LOCK|Z@!> | $197B | |||
| Medtronic PLC MDT | LOCK|kZMY?l | LOCK|cjfN | $134B | |||
| Stryker Corp SYK | LOCK|@lX&%D&$ | LOCK|T<r | $128B | |||
| Boston Scientific Corp BSX | LOCK|!@rr%> | LOCK|^!#^V | $65B | |||
| Edwards Lifesciences Corp EW | LOCK|fC?$<bKp | LOCK|t!xYw | $58B | |||
| GE HealthCare Technologies Inc Common Stock GEHC | LOCK|B?wk<%C | LOCK|#@! | $38B | |||
| DexCom Inc DXCM | LOCK|Y#s#f<&h | LOCK|nSb!@ | $31B | |||
| Koninklijke Philips NV ADR PHG | LOCK|pL | LOCK|Ydv | $30B | |||
| Steris PLC STE | LOCK|GQ^%^F@ | LOCK|!^<n | $25B | |||
| Zimmer Biomet Holdings Inc ZBH | LOCK|%tf%&$>r | LOCK|$V | $20B |
United States